Dr. Kenneth Castro, Director of CDC's Division of Tuberculosis Elimination, discusses the impact of TB on those who are HIV infected and the importance of detecting and curing TB.
Favorite
Health Professionals
2012
This is the seventeenth global report on tuberculosis (TB) published by WHO in a series that started in 1997. It provides a comprehensive and up-to-date assessment of the TB epidemic and progress in implementing and financing TB prevention, care and control at global, regional and country levels using data reported by 204 countries and territories that account for over 99% of the world’s TB cases.
Favorite
Health Professionals
International Agencies
Managers and Supervisors
Policy Makers
2012
Nine celebrities engaged in the fight against tuberculosis are launching a call to action to their friends and fans. They raise awareness through movies, music, television. They give patients a voice through their arts. They fight stigma and discrimination. They help with their time and commitment and need their efforts to be paired by other celebrities and their fans...
Favorite
Health Educators/Communicators
Health Professionals
International Agencies
2012
The purpose of this document is to provide operational guidance to NGOs and other CSOs and NTPs or their equivalents in implementing and scaling-up integrated community-based TB prevention, diagnosis, treatment and care using the ENGAGE-TB approach described in the document. The principles are aligned with the Stop TB Strategy and are complementary to existing guidelines for engaging all health care providers (including NGOs) in TB prevention and care as part of a public–private mix.
Favorite
Community Leaders
International Agencies
Social Service Providers
2012
The handout describes the main characteristics of LTBI and Active TB, as well as their differences. The material also describes what increases the risk for developing Active TB and how to prevent TB from developing.
Favorite
General Public
Persons With LTBI
2012
The Tuberculosis Drug Information Guide, 2nd edition, is derived from Drug-Resistant Tuberculosis: A Survival Guide for Clinicians (2nd edition) produced in 2008. Two additional drugs, ofloxacin and clarithromycin (which are used primarily outside of the US), have been included. This Guide can help any physician, nurse, or pharmacist who participates in the management of patients with TB or LTBI.
Favorite
Health Professionals
2012
The recommendations in this manual are based on assessments of the risks associated with different technical procedures performed in different types of TB laboratories. The manual describes the basic requirements for facilities and practices, which can be adapted to follow local or national regulations or as the result of a risk assessment.
Favorite
Lab Personnel
2012
A 2-hour webinar covers some common questions around LTBI treatment that may not be addressed in national guidelines, but represent a sample of everyday challenges shared by providers of LTBI care.
Favorite
Health Professionals
2012
A 90-minute webinar about the basics of reading radiographs to diagnose TB disease. Intended for physicians and nurses who diagnose TB.
Favorite
Health Professionals
2012
A 2-hour webinar focuses on tools and strategies State and local health departments can use to help private providers (including Federally Qualified Health Centers, Community Health Clinics, HMOs, and smaller practice practitioners) get up-to-speed on the diagnosis and treatment of latent TB infection (LTBI).
Favorite
Health Professionals
Managers and Supervisors
Social Service Providers
2012
This infographic discusses the global impact of multidrug-resistant TB (MDR TB). Two patient stories are also included in the infographic.
Favorite
General Public
2012
This information sheet discusses the once-a-week 12-week treatment of rifapentine and isoniazid for latent TB infection (LTBI). It explains LTBI, why it is necessary to treat it, the treatment plan and how it is managed, and a chart for tracking. It also includes hints on how to take the medicine including eating before taking it and avoiding alcohol, and describes normal side effects and possible problems including which signs and symptoms require you to call the doctor or nurse and what to do when taking a dose of medicine in the absence of medical staff...
Favorite
General Public
2012
This information sheet discusses treatment for latent TB infection. It reminds patients to keep their weekly medical visits, explains directly observed therapy, provides a list of items to discuss with their doctor, a medication schedule, and advises them to call the doctor immediately if they experience any of the side effects on the list...
Favorite
General Public
Persons With LTBI
2012
This information sheet discusses multidrug-resistant TB (MDR TB), a strain of TB that is resistant to at least two of the best anti-TB drugs, isoniazid and rifampicin. It describes TB disease, MDR TB, extensively drug resistant TB (XDR TB), TB transmission, how drug resistance happens, and who is at risk for getting MDR TB...
Favorite
Health Professionals
2012
This information sheet discusses infection control measures for health care settings to ensure prompt detection, take airborne precautions, and treat persons with suspected or diagnosed tuberculosis infection. It suggests that policies and procedures for TB control should be developed, reviewed periodically, and evaluated to minimize transmission risk...
Favorite
Health Professionals
2012
This information sheet discusses TB and the risk for international travelers. It explains TB transmission, multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains of the disease, and how drug resistance occurs. The information sheet considers whether international travelers are at risk of MDR or XDR TB while traveling, the risk of acquiring TB on an airplane, how TB can be prevented, TB vaccine, and what an individual should do before traveling internationally and if an individual thinks that he/she may have been exposed to someone with TB disease...
Favorite
General Public
2012
This information sheet explains TB for employers in non-healthcare settings. It describes TB disease, latent TB infection (LTBI), active TB, how it is determined whether a patient has active TB or LTBI, the symptoms of TB, what one should do if an employee reports having positive TB or has been in contact with someone with TB, and what happens after the employer contacts the local or state TB program...
Favorite
General Public
Health Professionals
2012
This MDR TB online course exists as a free self-learning online tool in allowing physicians worldwide to learn and test their knowledge of MDR TB. It is accredited by the South African Medical Association and the Norwegian Medical Association. The course contains seven modules and covers etiology and pathogenesis of TB, diagnosis and treatment, special situations, patient-physician communication, treatment adherence, and TB infection and control...
Favorite
Physicians
2012
This fact sheet discusses TB and how it is affected by the HIV. It defines TB and explains the difference between TB infection and latent TB infection. The fact sheet advises that HIV weakens the immune system increasing the chance that in people with HIV and latent TB, the TB germs will become active and attack the body causing TB disease...
Favorite
General Public
2012
Using a question and answer format, this fact sheet provides general information on TB prevention. It discusses TB transmission, infection, disease, diagnosis through a skin test or a special TB blood test, and treatment. It explains that TB is spread by germs that are in the air after someone with TB disease sneezes, coughs, speaks, laughs, or sings...
Favorite
People who inject drugs
2012
